Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
Anti-obesity drug therapy can be offered as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an initial body mass index (BMI) of 30 kg/m 2 or 2730 kg/m 2 in the presence of at least one weight-related comorbidity, e.g., dysglycemia, hypertension, dyslipidemia, or obstructive sleep apnea
Sergey Terushkin or a licensed provider may issue a prescription following your evaluation
Choose it when: you are tired, not very hungry, or need dinner in five minutes
offers plans designed by medical experts to make sure patients stay comfortable and understand their weekly schedules
How Tirzepatide Works GLP-1 (Glucagon-Like Peptide-1) Mimics the natural gut hormone that: Stimulates insulin release when blood sugar is high Slows stomach emptying (so you feel full longer) Reduces appetite signals to the brain GIP (Glucose-Dependent Insulinotropic Polypeptide) The "second incretin" that: Enhances insulin secretion beyond GLP-1 alone May improve fat metabolism Contributes to the superior weight loss seen in trials FDA Approval Timeline Clinical Trial Results Sources: SURMOUNT-1 [1] , SURMOUNT-2 [11] , and SURPASS [2] trial publications HOW TO USE THE LABEL DIFFERENCE TO YOUR ADVANTAGE The Same-Drug Insurance Arbitrage Same Drug, Different Coverage Zepbound and Mounjaro are identical medications same molecule, same doses, same manufacturer
US$ 24.01
US$ 27.56
US$ 27.13
US$ 21.43
US$ 21.66
US$ 24.72
US$ 23.18
US$ 20.44
